To evaluate salivary adiponectin and adenosine deaminase (ADA) in women suffering from Sjögren’s syndrome (SS).
Salivary adiponectin and ADA were measured in patients with SS (n = 17) and compared to their values in healthy controls (n = 13) and patients suffering from drug-induced xerostomia (non-SS sicca group; n = 19). A clinical history was made for each patient, patients were examined clinically, and xerostomia inventory (XI) was performed.
Salivary adiponectin corrected by total protein was higher in patients with SS than in healthy individuals (P < 0.05) or patients with non-SS sicca (P < 0.01) and correlated with XI (r = 0.555; P < 0.05). Salivary ADA was higher in patients with SS and non-SS sicca compared to controls (P < 0.05 in both cases).
The results of the present study indicate that adiponectin and ADA are increased in the saliva of patients with SS.
Salivary adiponectin corrected by total protein can be a potential biomarker of SS.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Guggenheimer J, Moore PA (2003) Xerostomia: etiology, recognition and treatment. J Am Dent Assoc 134:61–69. https://doi.org/10.14219/JADA.ARCHIVE.2003.0018
Villa A, Wolff A, Narayana N et al (2016) World workshop on oral medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis 22:365–382. https://doi.org/10.1111/odi.12402
Ergun S, Çekici A, Topcuoglu N et al (2010) Oral status and Candida colonization in patients with Sjögren’s syndrome. Med Oral Patol Oral Cir Bucal Mar 11515:310–315. https://doi.org/10.4317/medoral.15.e310
Manoussakis MN, Moutsopoulos HM (2000) Sjögren’s syndrome: autoimmune epithelitis. Best Pract Res Clin Rheumatol 14:73–95. https://doi.org/10.1053/BERH.1999.0078
Fox RI (2005) Sjögren’s syndrome. Lancet (London, England) 366:321–331. https://doi.org/10.1016/S0140-6736(05)66990-5
Delaleu N, Jonsson MV, Appel S, Jonsson R (2008) New concepts in the pathogenesis of Sjögren’s syndrome. Rheum Dis Clin N Am 34:833–845, vii. https://doi.org/10.1016/j.rdc.2008.08.004
Katsiougiannis S, Wong DTW (2016) The proteomics of saliva in Sjögren’s syndrome. Rheum Dis Clin N Am 42:449–456. https://doi.org/10.1016/j.rdc.2016.03.004
Rhodus N, Dahmer L, Lindemann K et al (1998) s-IgA and cytokine levels in whole saliva of Sjögren’s syndrome patients before and after oral pilocarpine hydrochloride administration: a pilot study. Clin Oral Investig 2:191–196. https://doi.org/10.1007/s007840050069
Kang EH, Lee YJ, Hyon JY et al (2011) Salivary cytokine profiles in primary Sjögren’s syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios. Clin Exp Rheumatol 29:970–976
Katsiougiannis S, Kapsogeorgou EK, Manoussakis MN, Skopouli FN (2006) Salivary gland epithelial cells: a new source of the immunoregulatory hormone adiponectin. Arthritis Rheum 54:2295–2299. https://doi.org/10.1002/art.21944
De Sanctis JB, Zabaleta M, Bianco NE et al (2009) Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 42:272–274. https://doi.org/10.1080/08916930902828031
Zamani B, Jamali R, Jamali A (2012) Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatol Int 32:1967–1975. https://doi.org/10.1007/s00296-011-1912-0
Salesi M, Ghazvini RA, Farajzadegan Z et al (2012) Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate. J Res Pharm Pract 1:72–76. https://doi.org/10.4103/2279-042X.108374
Saghiri R, Ghashghai N, Movaseghi S et al (2012) Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern. Rheumatol Int 32:1633–1638. https://doi.org/10.1007/s00296-011-1836-8
Torgutalp M, Efe C, Babaoglu H, Kav T (2017) Relationship between serum adenosine deaminase levels and liver histology in autoimmune hepatitis. World J Gastroenterol 23:3876–3882. https://doi.org/10.3748/wjg.v23.i21.3876
Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451. https://doi.org/10.1210/er.2005-0005
Su Y-C, Xiang R-L, Zhang Y et al (2013) Decreased submandibular adiponectin is involved in the progression of autoimmune sialoadenitis in non-obese diabetic mice. Oral Dis 20:n/a. https://doi.org/10.1111/odi.12197
Iizuka H, Koizumi H, Kamigaki K et al (1981) Two forms of adenosine deaminase in pig epidermis. J Dermatol 8:91–95. https://doi.org/10.1111/j.1346-8138.1981.tb02573.x
MacDermott RP, Tritsch GL, Formeister JF (1980) Adenosine deaminase and nucleoside phosphorylase activities in normal human blood mononuclear cell subpopulations. Clin Exp Immunol 42:303–307
Sullivan JL, Osborne WRA, Wedgwood RJ (1977) Adenosine deaminase activity in lymphocytes. Br J Haematol 37:157–158. https://doi.org/10.1111/j.1365-2141.1977.tb08825.x
Rai B, Kaur J, Jacobs R, Anand SC (2011) Adenosine deaminase in saliva as a diagnostic marker of squamous cell carcinoma of tongue. Clin Oral Investig 15:347–349. https://doi.org/10.1007/s00784-010-0404-z
Saracoglu U, Guven O, Durak I (2005) Adenosine deaminase and 5′-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis 11:323–325. https://doi.org/10.1111/j.1601-0825.2005.01131.x
Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558. https://doi.org/10.1136/ARD.61.6.554
Löe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38:610–616. https://doi.org/10.1902/jop.1967.38.6_part2.610
Thomson WM (2007) Measuring change in dry-mouth symptoms over time using the xerostomia inventory. Gerodontology 24:30–35. https://doi.org/10.1111/j.1741-2358.2007.00137.x
Tvarijonaviciute A, Aznar-Cayuela C, Rubio CP et al (2017) Evaluation of salivary oxidate stress biomarkers, nitric oxide and C-reactive protein in patients with oral lichen planus and burning mouth syndrome. J Oral Pathol Med 46:387–392. https://doi.org/10.1111/jop.12522
Tvarijonaviciute A, Castillo C, Ceron JJ et al (2017) Leptin and NGF in saliva of patients with diabetes mellitus type 2: a pilot study. J Oral Pathol Med 46:853–855. https://doi.org/10.1111/jop.12587
Lopez-Jornet P, Cayuela CA, Tvarijonaviciute A et al (2016) Oral lichen planus: salival biomarkers cortisol, immunoglobulin A, adiponectin. J Oral Pathol Med 45:211–217. https://doi.org/10.1111/jop.12345
Delacour H, Bousquet A, Fontan E, Ceppa F (2013) Ammonia does not interfere with the Diazyme adenosine deaminase test. Clin Chem Lab Med 51:e225–e226. https://doi.org/10.1515/cclm-2013-0115
Toussirot E, Gaugler B, Bouhaddi M et al (2010) Elevated adiponectin serum levels in women with systemic autoimmune diseases. Mediat Inflamm 2010(938408):–6. https://doi.org/10.1155/2010/938408
Augusto KL, Bonfa E, Pereira RMR et al (2016) Metabolic syndrome in Sjögren’s syndrome patients: a relevant concern for clinical monitoring. Clin Rheumatol 35:639–647. https://doi.org/10.1007/s10067-015-3072-1
Contreras-Aguilar MD, Escribano D, Martínez-Subiela S et al (2017) Influence of the way of reporting alpha-amylase values in saliva in different naturalistic situations: a pilot study. PLoS One 12:e0180100. https://doi.org/10.1371/journal.pone.0180100
Barranco T, Tvarijonaviciute A, Tecles F, et al. (2017) Changes in CK, LDH and AST in saliva samples after an intense exercise: a pilot study. J Sports Med Phys Fitness. doi: https://doi.org/10.23736/S0022-4707.17.07214-0
Sasaki T, Nakajima H (1992) Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. J Am Acad Dermatol 27:411–414. https://doi.org/10.1016/0190-9622(92)70209-X
Herken H, Gurel A, Selek S et al (2007) Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 38:247–252
AT was financially supported by the Program “Juan de la Cierva Incorporacion” of “Ministerio de Economia y Competitividad,” Spain, through a post-doctoral grant.
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
About this article
Cite this article
Tvarijonaviciute, A., Zamora, C., Martinez-Subiela, S. et al. Salivary adiponectin, but not adenosine deaminase, correlates with clinical signs in women with Sjögren’s syndrome: a pilot study. Clin Oral Invest 23, 1407–1414 (2019). https://doi.org/10.1007/s00784-018-2570-3
- Adenosine deaminase
- Clinical signs